Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs. 1979

H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa

Stimulation of [(3)H]thymidine incorporation of thymocytes and splenocytes from guinea pigs by various bacterial cell walls and their peptidoglycans, by enzymatic digests, and by synthetic muramyl dipeptides was studied as an indication of mitogenic activity. Cell wall and peptidoglycan preparations, isolated from 19 strains belonging to 18 different species, definitely increased [(3)H]thymidine incorporation of thymocytes as well as splenocytes, regardless of mycolic acid contents as a non-peptidoglycan component. Both the cell walls from Nocardia corynebacteriodes (containing mycolic acids) and those from Streptomyces gardneri (lacking mycolic acids) showed far stronger mitogenic activities on splenocytes than other cell walls (stimulation index, 25 to 30). Furthermore, water-soluble enzymatic digests, notably the endopeptidase digests, which generally were greater in degree of polymerization of peptidoglycan subunits than the glycosidase digests obtained from representative cell walls, were found to have as distinct a stimulating activity on splenocytes as the original cell walls. In contrast, solubilization of the cell walls by enzymes, irrespective of endopeptidases or glycosidases, was accompanied by disappearance of the mitogenic activity on thymocytes. On the other hand, studies with synthetic 6-O-acyl-MurNAc-l-Ala-d-isoGln preparations (6-O-acyl-MDPs) revealed that 6-O-stearoyl-MDP and 6-O-(2-tetradecylhexadecanoyl)-MDP, unlike MDP, had distinct mitogenic activity on thymocytes, whereas their activity on splenocytes was rather weaker than MDP itself. The findings presented here suggest that MDP is the minimal structure for the mitogenic activities of bacterial cell walls on guinea pig splenocytes, but that MDP, though distinctively active by itself, requires a polymerized form to exert effectively its inherent stimulating activities on splenocytes. On the other hand, on thymocytes, MDP, unless it takes a particular form or has appropriate additive groups, cannot exert its mitogenic activities.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D010457 Peptidoglycan A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. Murein,Pseudomurein
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000119 Acetylmuramyl-Alanyl-Isoglutamine Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity. Mur-NAc-L-Ala-D-isoGln,Muramyl Dipeptide,Acetylmuramyl Alanyl Isoglutamine,N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide,N-Acetylmuramyl-L-Alanyl-D-Isoglutamine,Alanyl Isoglutamine, Acetylmuramyl,Dipeptide, Muramyl,Isoglutamine, Acetylmuramyl Alanyl,Mur NAc L Ala D isoGln,N Acetyl Muramyl L Alanyl D Glutamic alpha Amide,N Acetylmuramyl L Alanyl D Isoglutamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
June 1980, Biken journal,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
January 1983, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
February 1982, Infection and immunity,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
June 1982, [Osaka Daigaku shigaku zasshi] The journal of Osaka University Dental Society,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
February 1981, Infection and immunity,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
January 1990, In vivo (Athens, Greece),
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
January 1970, American Industrial Hygiene Association journal,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
January 1985, Advances in experimental medicine and biology,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
January 1986, Toxicology letters,
H Takada, and M Tsujimoto, and S Kotani, and S Kusumoto, and M Inage, and T Shiba, and S Nagao, and I Yano, and S Kawata, and K Yokogawa
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!